The Southern California Extracorporeal Membrane Oxygenation Consortium During the Coronavirus Disease 2019 Pandemic

Mazen Odish1, Cassia Yi1, Juliann Eigner2

  • 1University of California, San Diego Health, San Diego, California, USA.

Insights

The Southern California ECMO Consortium ensured equitable resource allocation for extracorporeal membrane oxygenation (ECMO) during the COVID-19 pandemic. This collaborative model successfully treated 97 patients without capacity-related denials, optimizing critical care delivery.

Area of Science:

  • Critical Care Medicine
  • Pandemic Preparedness
  • Health Systems Management

Background:

  • The COVID-19 pandemic created unprecedented demand for critical care resources, including extracorporeal membrane oxygenation (ECMO).
  • Effective management of limited ECMO resources was crucial for equitable patient care during the public health crisis.
  • A coordinated regional approach was necessary to address potential resource limitations.

Purpose of the Study:

  • To establish guidelines for equitable and resource-effective ECMO delivery during the COVID-19 pandemic in San Diego County.
  • To create a collaborative model for managing ECMO resources across multiple centers.
  • To ensure maximal community benefit from limited ECMO availability.

Main Methods:

  • Formation of the Southern California Extracorporeal Membrane Oxygenation (ECMO) Consortium involving 4 San Diego County centers.
  • Development of guidelines reviewed by a biomedical ethicist and integrated into county resource allocation plans.
  • Implementation of weekly virtual conferences for capacity monitoring, data sharing, and case discussion.
  • Facilitation of equipment exchange between centers to maximize regional capacity.

Main Results:

  • The consortium successfully placed 97 patients on ECMO between March 1 and November 30, 2020.
  • No eligible patients were denied ECMO due to lack of resources or capacity.
  • The collaborative model ensured equitable access to critical care.

Conclusions:

  • The Southern California ECMO Consortium effectively optimized ECMO resource allocation during the COVID-19 pandemic.
  • The consortium's model demonstrates a successful strategy for managing scarce critical care resources.
  • This approach can serve as a valuable template for other regions facing similar public health emergencies.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
592
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
432
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
258
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
474
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
308
Oxygen Delivering System I: Nasal Cannula and Face Mask01:26

Oxygen Delivering System I: Nasal Cannula and Face Mask

The human body requires oxygen to function, and when the natural process of respiration is hindered, external devices, including the following, are needed to help deliver this vital gas.
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
843